The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi‐centre, controlled, randomised, blinded, clinical trial

In a randomised, controlled study, we compared the efficacy of Grafix(®), a human viable wound matrix (hVWM) (N = 50), to standard wound care (n = 47) to heal diabetic foot ulcers (DFUs). The primary endpoint was the proportion of patients with complete wound closure by 12 weeks. Secondary endpoints...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavery, Lawrence A, Fulmer, James, Shebetka, Karry Ann, Regulski, Matthew, Vayser, Dean, Fried, David, Kashefsky, Howard, Owings, Tammy M, Nadarajah, Janaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951030/
https://www.ncbi.nlm.nih.gov/pubmed/25048468
http://dx.doi.org/10.1111/iwj.12329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951030/
https://www.ncbi.nlm.nih.gov/pubmed/25048468
http://dx.doi.org/10.1111/iwj.12329

Ejemplares similares